Diurnal Group PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.27 |
Market Cap |
GBP25.78 M |
Shares Outstanding |
84.53 M |
Public Float |
21.13 M |
Address |
Cardiff Medicentre Cardiff South Glamorgan CF14 4UJ United Kingdom |
Employees | - |
Website | http://diurnal.co.uk |
Updated | 07/08/2019 |
Diurnal Group Plc is a specialty pharmaceutical company which addresses the unmet clinical and patient needs for hormone replacement treatments by creating products for life-long treatment for the chronic conditions, which include adrenal insufficiency, rheumatoid arthritis, hypogonadism and hypothryroidism. Its hormone therapeutics is used for proprietary formulations and novel physiological treatment regimes of approved drugs. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. |